Constanza Morén

researcher

Constanza Morén is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-6848-7407

P108employerUniversity College LondonQ193196
University of BarcelonaQ219615
Leonard M. Miller School of MedicineQ6525526
Royal Free HospitalQ7374196
Institute for Research and Technology in Food and AgricultureQ9006472
Institute of Marine SciencesQ11926742
Instituto de Productos Naturales y AgrobiologíaQ30263829
Fundació Clínic per a la Recerca BiomèdicaQ30287378
Centre for Biomedical Network Research on Rare DiseasesQ30296152
Foundation for Research and Prevention of AIDS in SpainQ45135795
University College London Medical School - Royal Free CampusQ86028187
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q124979860A Mitocentric View of the Main Bacterial and Parasitic Infectious Diseases in the Pediatric Population
Q112288356A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Q47120743Addendum: Morén, C.; Hernández, S.; Guitart-Mampel, M.; Garrabou, G. Mitochondrial Toxicity in Human Pregnancy: An Update on Clinical and Experimental Approaches in the Last 10 Years. Int. J. Environ. Res. Public Health 2014, 11, 9897–9918.
Q39800044BACE-1, PS-1 and sAPPβ levels are increased in plasma from sporadic inclusion body myositis patients: surrogate biomarkers among inflammatory myopathies.
Q90263483Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
Q64040134Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment
Q101125479Decreased Glycolysis as Metabolic Fingerprint of Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension
Q40998695Decreased Mitochondrial Function Among Healthy Infants Exposed to Antiretrovirals During Gestation, Delivery and the Neonatal Period.
Q101215006Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus
Q42938219Evolution of mitochondrial DNA content after planned interruption of HAART in HIV-infected pediatric patients
Q54976661Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease.
Q91373313GBA mutation promotes early mitochondrial dysfunction in 3D neurosphere models
Q43271718Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemia
Q37604361HIV-1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion.
Q57631516Hyperbaric oxygen therapy for carbon monoxide poisoning
Q43296433Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Q64039240Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers
Q51703326Mitochondrial DNA (mtDNA) variants in the European haplogroups HV, JT, and U do not have a major role in schizophrenia.
Q44128587Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women
Q51490832Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis.
Q57631525Mitochondrial Injury in Human Acute Carbon Monoxide Poisoning: The Effect of Oxygen Treatment
Q96303722Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients
Q41276695Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicity
Q64764170Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations
Q57631521Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART
Q50551965Mitochondrial damage in adipose tissue of untreated HIV-infected patients.
Q41721533Mitochondrial disturbances in HIV pregnancies
Q59217093Mitochondrial effects of 3 years of CD4-guided HIV treatment interruption
Q54322317Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues.
Q45365531Mitochondrial impact of human immunodeficiency virus and antiretrovirals on infected pediatric patients with or without lipodystrophy
Q34348392Mitochondrial toxicity in human pregnancy: an update on clinical and experimental approaches in the last 10 years
Q47438814Molecular basis of reduced birth weight in smoking pregnant women: mitochondrial dysfunction and apoptosis
Q112366884Neuronal induction and bioenergetics characterization of human forearm adipose stem cells from Parkinson's disease patients and healthy controls
Q44108125Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.
Q57316869Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn
Q40318981Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine
Q55059717Severe TK2 enzyme activity deficiency in patients with mild forms of myopathy.
Q43496856Study of oxidative, enzymatic mitochondrial respiratory chain function and apoptosis in perinatally HIV-infected pediatric patients
Q38783524The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity.
Q44817068The effects of sepsis on mitochondria
Q51765978Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.

Search more.